Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Matthew Biegler from Oppenheimer issued a price target of $12.00 for CTMX on 2026-03-16 13:30:00.The adjusted price target was set to $12.00.At the time of the announcement, CTMX...
March 16, 2026 CTMX 61.43%
Jeffrey Stantial from Stifel Nicolaus issued a price target of $2.50 for CNTY on 2026-03-13 19:05:00.The adjusted price target was set to $2.50.At the time of the announcement,
March 13, 2026 CNTY 3.05%
Jay Olson from Oppenheimer issued a price target of $140.00 for NKTR on 2026-03-13 16:39:00.The adjusted price target was set to $140.00.At the time of the announcement, NKTR...
March 13, 2026 NKTR 0.02%
Jasper Bibb from Truist Financial issued a price target of $55.00 for APEI on 2026-03-13 15:06:00.The adjusted price target was set to $55.00.At the time of the announcement,
March 13, 2026 APEI -4.49%
Jeffrey Stantial from Stifel Nicolaus issued a price target of $3.00 for CNTY on 2026-03-13 13:15:00.The adjusted price target was set to $3.00.At the time of the announcement,
March 13, 2026 CNTY 3.05%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| CTMX CytomX Therapeutics, Inc. | 7.56
61.43% | ||||||||||||||||||
| RBOT Vicarious Surgical Inc. | 0.70
29.39% | ||||||||||||||||||
| TOI The Oncology Institute, I | 3.43
20.77% | ||||||||||||||||||
| LCUT Lifetime Brands, Inc. | 4.59
20.47% | ||||||||||||||||||
| CVGI Commercial Vehicle Group, | 3.47
19.66% | ||||||||||||||||||
| WGSWW WGSWW | 0.01
19.51% | ||||||||||||||||||
| LPTX Leap Therapeutics, Inc. | 0.69
19.02% | ||||||||||||||||||
| CARM Carisma Therapeutics, Inc | 0.04
18.38% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 5.40%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -3.55%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 2.55%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 1.21%